Imunon, Inc. (IMNN)
NASDAQ · Healthcare
Imunon, Inc. Operating Income 2017–2022
Imunon, Inc. annual/quarterly operating income history and growth rate from 2017 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Imunon, Inc. operating income for the quarter ending September 30, 2022 was -6.2 M, a 21.99% increase year-over-year.
- Imunon, Inc. operating income for the twelve months ending September 30, 2022 was -23.1 M, a 18.96% increase year-over-year.
- Imunon, Inc. annual operating income for 2022 was -24.9 M, a 18.63% increase from 2021.
- Imunon, Inc. annual operating income for 2021 was -21.0 M, a 13.64% increase from 2020.
- Imunon, Inc. annual operating income for 2020 was -18.5 M, a 10.11% decrease from 2019.
- Imunon, Inc. annual operating income for 2019 was -20.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Imunon, Inc. Operating Income — FAQ
Imunon, Inc. (IMNN) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Imunon, Inc.'s operating income?
Imunon, Inc. (IMNN) reported operating income of -$25M for fiscal 2022.
Where can I see IMNN's operating income history?
The chart and table above show Imunon, Inc.'s operating income by year and by quarter, including the growth rate.